Sat.Apr 03, 2021 - Fri.Apr 09, 2021

article thumbnail

Is disability the last bastion of the representation debate?

pharmaphorum

From #MeToo to Black Lives Matter, as a society we have been discussing the relationship between representation and equality more than ever over the last few years. . But while progress is being made in so many areas, people with disabilities are still struggling to find a voice above the accepted narrative, says Ross Lannon, the 27-year-old blogger and multi-media content creator behind A Life on Wheels.

article thumbnail

Charles River, Valence Discovery partner on AI-aided drug design

Outsourcing Pharma

The collaboration will enable Charles River clients to access Valenceâs artificial intelligence platform in their pharmaceutical development projects.

93
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Best Lacri-Lube alternative eye ointments

Druggist

Lacri-lube has been out of stock for months. Still, after all this time, some patients get repeat prescriptions issued with Laci-Lube on it. Patients who have Lacri-Lube eye ointment on their ‘repeats’ should contact their surgery and ask to remove it and replace it with Lacri-lube alternative eye ointments. I will list in this post the best Lacri-Lube alternative eye ointments and gels.

93
article thumbnail

Protected: Digital TV: A Boon for Pharma Marketers

Pharma Marketing Network

This content is password protected. To view it please enter your password below: Password: The post Protected: Digital TV: A Boon for Pharma Marketers appeared first on Pharma Marketing Network.

52
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Digital tool will be tested against COVID-19 ‘brain fog’

pharmaphorum

A digital tool used to treat attention-deficit hyperactivity disorder (ADHD) is being tested to see if it can help counter lingering, fuzzy thinking in COVID-19 survivors, a condition sometimes known as ‘brain fog’ An app called EndeavorRx – developed by PureTech Health-backed Akili Interactive – will be tested in two clinical trials to see if it can improve cognitive function in people who have recovered from COVID-19 but still show cognitive problems weeks or months later.

Hospitals 128
article thumbnail

Dive into advanced data, ethical issues at free online event

Outsourcing Pharma

The April 6 webinar, Clinical Development Innovations, will touch upon artificial intelligence, machine learning, ethics and other impactful issues.

83

More Trending

article thumbnail

A Guide to Isolation Gown Selection

Pharma Mirror

Isolation gowns are essential equipment for infection-control strategies. They are the second most used PPE items after gloves. They were originally designed for health workers but can also be worn by random people to protect them from infections when they come in contact with infected people or substances. The different types of isolation gowns There are two major types of isolation gowns made for healthcare purposes: Surgical gowns: A surgical gown is a personal protective garment that is used

52
article thumbnail

The next generation of immunotherapy? Innate Pharma targets NK cells

pharmaphorum

Clinical-stage oncology biotech Innate Pharma is on a mission to harness the power of natural killer cells to fight cancer. Catherine Longworth spoke to CEO Mondher Mahjoubi to find out the science behind this next generation of immunotherapies. . Founded in 1999, Marseille-based company Innate Pharma is on a mission to develop immunotherapies that take advantage of the body’s innate immune system.

article thumbnail

CISCRP event to boost public awareness of clinical research

Outsourcing Pharma

The AWARE for All virtual event series aims to educate and engage the public as important partners in clinical trials and development of new treatments.

72
article thumbnail

COVID-19 lateral flow tests available from pharmacies

Druggist

A new pharmacy service was recently launched in England, which allows the public to collect free COVID-19 lateral flow tests (lateral flow devices – LFDs) from community pharmacies. The NHS Community Pharmacy COVID -19 Lateral Flow Device (LFD) Distribution Service was launched on the 29th of March 2021, but the promotion of this service to the public will not start after Easter.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Updated Report on State Policy Efforts to Expand Access to Contraception in Pharmacies

Birth Control Pharmacist

Free 22-page report describing the current landscape of direct pharmacy access to contraception in pharmacies, state policy approaches and experiences, as well as implementation. The 2020 report includes information for policy efforts in 2020, along with emphasis on definitions of reimbursement vs. payment and a new appendix with model bill elements. .

52
article thumbnail

Provention faces delay in FDA review of diabetes prevention antibody

pharmaphorum

The FDA says it has uncovered “deficiencies” in the marketing application for Provention Bio’s much-anticipated drug teplizumab for the prevention of type 1 diabetes (T1D) that could delay its review. The issues are holding up discussions between the agency and company about labeling and post-marketing requirements for teplizumab, and are concentrated around the pharmacokinetics data for the antibody, and whether it is comparable to the drug that its original developer Eli Lill

FDA 98
article thumbnail

Patient-centric approach more important than ever: Deloitte

Outsourcing Pharma

Especially with the COVID-19 pandemic impacting studies, the company says, putting patients at the center of studies and trial tech must be top priority.

72
article thumbnail

Services from Your Pharmacy You May Be Missing Out On

Lifewell Rx Pharmacy

Most of us go to the pharmacy to get our prescriptions, an occasional treat, or a toiletry item. But did you know that they can do so much more for you? As the community’s leading independent pharmacy in Louisville, Kentucky , at LIFEWELL RX PHARMACY here are some of the services from your pharmacy that you may be missing out on: Pharmacy consultations.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

COVID-19: Future’s so bright… I gotta wear shades

The Infectious Pharmacist

Photo by asim alnamat on Pexels.com. A friend of mine says that every news report should come with a warning similar to that for cigarettes: “Warning, this news report contains information that is both addictive and will be harmful to your mental health.” I think the same could be said for announcements by public health professionals. Listen, I get it, public health officials have to thread a very narrow needle.

article thumbnail

COVID heralds a faster future for drug development (if stakeholders can collaborate)

pharmaphorum

COVID-19 has been a trial-by-fire showing just how quickly drugs and vaccines can be developed under the right circumstances – but there is much to do to ensure this progress is not lost, said speakers at WIRED Health 2021, including the CEOs of BioNTech and BenevolentAI. . The 2021 WIRED Health conference took a broad view of the current pandemic situation, with speakers ranging from geneticists to intensive care doctors.

article thumbnail

Patient centricity vital to advancing rare-disease treatments: ICON

Outsourcing Pharma

A leader from the global CRO discusses how putting the patient first in clinical research is essential to discovering new therapies for orphan diseases.

70
article thumbnail

Leadership Series II: Work Life Balance a Myth?

Colors Make me Happy

The COVID19 pandemic has amplified work-life challenges for many work-from-home employees as boundaries between work and home life become blurred. In these difficult times, the reality is that we need to make a living, but also need to make sure that we are still “living” to avoid becoming burned out. To address these new challenges, many companies have focused on employee well-being and have associated a work-life imbalance with excessive work demands.

52
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

6 Ways to Automate your Sales and Marketing Efforts

Mission-Driven Marketing Blog

Inbound Marketing, a methodology which seeks to attract leads through generating valuable content and experiences, has been outpacing traditional forms of marketing, like Outbound Marketing or ‘Push’ Marketing, in recent years. Inbound Marketing solves the problem of contacts being overwhelmed and oversaturated with marketing and sales messaging and builds longer-lasting, mutually-beneficial relationships.

52
article thumbnail

Jan van de Winkel: Building Europe’s biotech powerhouse at Genmab

pharmaphorum

Jan van de Winkel has overseen one of biotech’s big success stories since he took over Genmab’s CEO in 2010. He spoke to pharmaphorum’s news editor Richard Staines to outline his plans to create a European biotech powerhouse. . The last ten years has seen Denmark’s Genmab become one of biotech’s big success stories. Under the leadership of CEO Jan van de Winkel it has gone from financially precarious position following the stock market crash in the late noughties, to the darling of the Nasdaq wi

article thumbnail

Dedicated dad hopes to run down cure for a rare disease

Outsourcing Pharma

A father of two boys with Duchenne muscular dystrophy is running the Austin Marathon to raise funds toward pursuit of a cure for the rare, fatal disease.

58
article thumbnail

The Curse and Blessing of a Co-Dependent Personality

Colors Make me Happy

The term “co-dependency” was initially coined by Alcoholics Anonymous in 1950 to describe those individuals whose unhealthy choices enable and encourage their partner with addiction. While this is still true, co-dependency more recently has a much broader definition. Although it is not recognized as a clinical diagnosis or a personality disorder in the Diagnostic and Statistical Manual of Mental Disorders (DSM), co-dependency is an unhealthy and potentially toxic relational dynamic.

article thumbnail

Thousands to benefit from five-minute breast cancer treatment

Pharma Times

NHS England is rolling out Roche's new combined treatment Phesgo, which drastically cuts administration time

49
article thumbnail

Genmab could spin out autoimmune disease unit, says CEO

pharmaphorum

Genmab’s CEO Jan van de Winkel has said he would consider spinning out a smaller autoimmune diseases biotech, while ruling out any interest in a merger with big pharma. . In an interview with pharmaphorum, van de Winkel noted that the company’s drugs could be used for diseases outside of cancer, where Copenhagen-based Genmab first made its mark. A drug it originally developed to treat leukaemia has been repurposed by Novartis as a treatment for multiple sclerosis.

FDA 88
article thumbnail

IQVIA completes acquisition of Q2 Diagnostics

Outsourcing Pharma

The clinical research tech specialists, which had held 60% of Q2 Diagnostics, will now wholly own the comprehensive clinical laboratory services company.

56
article thumbnail

Doxepin and CYP2D6

Med Ed 101

We blogged about doxepin a few weeks ago now and I had a colleague bring this article to my attention. The relationship between doxepin and CYP2D6 is a very important one and I wanted to discuss it further with some potential drug interactions that may come up in practice. Here’s the abstract from the article. […]. The post Doxepin and CYP2D6 appeared first on Med Ed 101.

40
article thumbnail

Nationwide launch for pioneering fertility study

Pharma Times

The NIHR-funded trial will assess whether removing small fibroids and endometrial polyps improves fertility and live births

47
article thumbnail

Healx deploys its AI in hunt for Friedreich’s ataxia therapies

pharmaphorum

UK artificial intelligence specialist Healx has begun a partnership with two medical charities that aims to uncover new therapies for the neurodegenerative disease Friedreich’s ataxia (FA). . Healx has joined forces with Ataxia UK and the US-based Friedreich’s Ataxia Research Alliance (FARA) on the project, and will use its AI-powered drug discovery platform Healnet to try to find already used drugs that could be repurposed as treatments for FA.

81
article thumbnail

Severe winter storm wrought havoc on pharma supply chain

Outsourcing Pharma

An expert from FourKites shares impacts of the February storm that hit Texas and other parts of North America, and lessons can be learned from the event.

52
article thumbnail

[Webinar] Key Learnings and Insights from Leaders in Native Advertising

Pharma Marketing Network

Native advertising may mean something different to you depending on what part of the industry you’re in whether it be in advertising or publishing. . Tune in and listen to the Pharma Marketing Network and fellow thought leaders from, ROI Marketplace, MedThink, and Sharecare.com, discuss their learnings and insights on native advertising from each of their respective vantage points – pharma-marketer, publisher, and agency. .

article thumbnail

NICE 'no' for Opdivo/Yervoy lung cancer combo

Pharma Times

The combination is not considered to be a cost-effective use of NHS resources in this setting

46
article thumbnail

Cancer Research UK spinout Achilles raises $175.5m in IPO

pharmaphorum

UK biotech Achilles Therapeutics has completed its initial public offering (IPO) in the US, raising $175.5 million that will be used to take its personalised T cell therapy for lung and skin cancers through proof-of-concept trials. The new funding will also be used to advance two more T cell programmes for head and neck and kidney cancers into human testing, develop and expand its bioinformatics and manufacturing capabilities, and increase its use of automation, according to an SEC filing.

78
article thumbnail

PRA ‘toolkit’ pinpoints rare-disease clinical trial risks

Outsourcing Pharma

The free Patient-Centric Trial Development Toolkit is aimed toward helping sites and sponsors identify and minimize risks in rare-disease clinical studies.

52